Improving properties of baricitinib due to interaction with Pluronic micelles-Reference-Cited by-同舟云学术

Improving properties of baricitinib due to interaction with Pluronic micelles

Published:2023-07 Issue: Volume:382 Page:121968
ISSN:0167-7322
Container-title:Journal of Molecular Liquids
language:en
Short-container-title:Journal of Molecular Liquids

Author:

Garibyan Anna,Delyagina Ekaterina,Terekhova Irina^ORCID

Funder

Russian Science Foundation

Publisher

Elsevier BV

Subject

Materials Chemistry,Physical and Theoretical Chemistry,Spectroscopy,Condensed Matter Physics,Atomic and Molecular Physics, and Optics,Electronic, Optical and Magnetic Materials

Reference57 articles.

1. Baricitinib: First global approval;Markham;Drugs,2017

2. European Medicines Agency. Olumiant (baricitinib) film-coated tablets: EU summary of product characteristics. 2017. http://www.ema.europa.eu/. Accessed 10 Apr 2018.

3. Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050;Fridman;J. Immunol.,2010

4. Dose/exposure-response modeling to support dosing recommendation for phase 3 development of baricitinib in patients with rheumatoid arthritis;Zhang;CPT: Pharmacometrics & Systems Pharmacology,2017

5. Baricitinib in patients with refractory rheumatoid arthritis;Genovese;N. Engl. J. Med.,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complex formation with modified cyclodextrins for improving biopharmaceutical properties of baricitinib, a novel immunomodulatory drug;Journal of Molecular Liquids;2024-07

2. Design of polymeric carriers to enhance antimicrobial photodynamic inactivation;Journal of Drug Delivery Science and Technology;2024-04

3. Advances in Nanomaterials for Drug Delivery;Advances in Medical Diagnosis, Treatment, and Care;2023-11-03